380
Participants
Start Date
July 31, 2008
Primary Completion Date
October 31, 2011
Study Completion Date
October 31, 2011
Rivastigmine transdermal patch
Novartis Investigative Site, Randwick
Novartis Investigative Site, Hornsby
Novartis Investigative Site, East Gosford
Novartis Investigative Site, Gosford
Novartis Investigative Site, Fitzroy
Novartis Investigative Site, Heidelberg
Novartis Investigative Site, Ballarat
Novartis Investigative Site, Chemside
Novartis Investigative Site, Adelaide
Novartis Investigative Site, Woodville
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Bursa
Novartis Investigative Site, Meselik / Eskisehir
Novartis Investigative Site, Ipoh
Novartis Investigative Site, Mersin
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Altunizade
Novartis Investigative Site, Uskudar / Istanbul
Novartis Investigative Site, Izmir
Novartis Investigative Site, Izmir
Novartis Investigative Site, Talas / Kayseri
Novartis Investigative Site, Kocaeli
Novartis Investigative Site, Konya
Novartis Investigative Site, Kuala Lumpur
Novartis Investigative Site, Atakum / Samsun
Novartis Investigative Site, Kuala Lumpur
Novartis Investigative Site, Seremban
Novartis Investigative Site, Johor Bahru
Novartis Investigative Site, Nedlands
Novartis Investigative Site, Seoul
Novartis Investigative Site, Bundang
Novartis Investigative Site, Seoul
Novartis Investigative Site, Ankara
Novartis Investigative Site, Ankara
Novartis Investigative Site, Antalya
Novartis Investigative Site, Emek / Ankara
Novartis Investigative Site, Etlik / Ankara
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY